Imperial College London
Portrait Picture

DrMatthewHind

Faculty of Medicine, National Heart & Lung Institute

Honorary Research Officer
 
 
 
//

Contact

 

m.hind

 
 
//

Location

 

Royal BromptonRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Hopkinson:2016:10.1136/thoraxjnl-2016-208865,
author = {Hopkinson, NS and Polkey and Shah, P and Hind},
doi = {10.1136/thoraxjnl-2016-208865},
journal = {Thorax},
pages = {277--279},
title = {Endobronchial valves for patients with heterogeneous emphysema and without interlobar collateral ventilation – open label treatment following the BeLieVeR-HIFi study},
url = {http://dx.doi.org/10.1136/thoraxjnl-2016-208865},
volume = {72},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Outcomes in early trials of bronchoscopic lung volume reduction using endobronchial valves for the treatment of patients with advanced emphysema were inconsistent. However improvements in patient selection with focus on excluding those with interlobar collateral ventilation and homogeneous emphysema resulted in significant benefits in the BeLieVeR-HIFi study compared to sham treated controls. In this manuscript we present data from the control patients in the BeLieVeR-HIFi study who went on to have open label endobronchial valve treatment after completion of the clinical trial (n=12), combined with data from those in the treatment arm who did not have collateral ventilation (n=19). Three months after treatment the forced expiratory volume in the 1st second increased by 27.3(36.4)%, residual volume reduced by 0.49(0.76)L, the 6 minute walk distance increased by 32.6(68.7) m, and the St George Respiratory Questionnaire for COPD score improved by 8.2(20.2) points. These data extend the evidence for endobronchial valve placement in appropriately selected patients with COPD.
AU  - Hopkinson,NS
AU  - Polkey
AU  - Shah,P
AU  - Hind
DO  - 10.1136/thoraxjnl-2016-208865
EP  - 279
PY  - 2016///
SN  - 1468-3296
SP  - 277
TI  - Endobronchial valves for patients with heterogeneous emphysema and without interlobar collateral ventilation – open label treatment following the BeLieVeR-HIFi study
T2  - Thorax
UR  - http://dx.doi.org/10.1136/thoraxjnl-2016-208865
UR  - http://hdl.handle.net/10044/1/40489
VL  - 72
ER  -
Download